Artykuły udostępnione publicznie: - Prem Kumar SGWięcej informacji
Niedostępne w żadnym miejscu: 4
Pomalidomide–dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial
S Ailawadhi, JR Mikhael, BR LaPlant, KM Laumann, S Kumar, V Roy, ...
Leukemia 32 (3), 719-728, 2018
Upoważnienia: US National Institutes of Health
New national and regional bryophyte records, 76
LT Ellis, OM Afonina, M Alataş, HBM Alia, J Alvarez, AM Aponte Rojas, ...
Journal of Bryology 46 (1), 51-74, 2024
Upoważnienia: US National Science Foundation, German Research Foundation, Council of …
Daratumumab, Carfilzomib, Pomalidomide and Elotuzumab for the Treatment of POEMS Syndrome-The Mayo Clinic Experience
I Vaxman, S Kumar, F Buadi, M Lacy, D Dingli, S Hayman, T Kourelis, ...
Upoważnienia: US National Institutes of Health
High spin states in La
R Garg, S Kumar, M Saxena, S Goyal, D Siwal, S Verma, R Palit, S Saha, ...
Physical Review C—Nuclear Physics 87 (3), 034317, 2013
Upoważnienia: Council of Scientific and Industrial Research, India, Department of Science …
Dostępne w jakimś miejscu: 37
Changing cost of HIV interventions in the context of scaling-up in India
L Dandona, SGP Kumar, YK Ramesh, MC Rao, AA Kumar, E Marseille, ...
Aids 22, S43-S49, 2008
Upoważnienia: US National Institutes of Health
Depression among AIDS-orphaned children higher than among other orphaned children in southern India
SGP Kumar, R Dandona, GA Kumar, SP Ramgopal, L Dandona
International Journal of Mental Health Systems 8, 1-9, 2014
Upoważnienia: Wellcome Trust
Social network and risk-taking behavior most associated with rapid HIV testing, circumcision, and preexposure prophylaxis acceptability among high-risk Indian men
J Schneider, R Kumar, R Dandona, P Kumar, A Kumar, V Lakshmi, ...
AIDS Patient Care and STDs 26 (10), 631-640, 2012
Upoważnienia: US National Institutes of Health
Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India
L Dandona, SGP Kumar, YK Ramesh, MC Rao, E Marseille, JG Kahn, ...
BMC Health Services Research 8, 1-11, 2008
Upoważnienia: US National Institutes of Health
Candidate change agent identification among men at risk for HIV infection
JA Schneider, RB McFadden, EO Laumann, SGP Kumar, SR Gandham, ...
Social Science & Medicine 75 (7), 1192-1201, 2012
Upoważnienia: US National Institutes of Health
Outputs and cost of HIV prevention programmes for truck drivers in Andhra Pradesh, India
SGP Kumar, R Dandona, JA Schneider, YK Ramesh, L Dandona
BMC health services research 9, 1-8, 2009
Upoważnienia: US National Institutes of Health
Contact with HIV prevention programmes & willingness for new interventions among truckers in India
SGP Kumar, GA Kumar, R Poluru, JA Schneider, L Dandona, L Vemu, ...
Indian Journal of Medical Research 137 (6), 1061-1071, 2013
Upoważnienia: US National Institutes of Health
Deep learning‐based virtual noncalcium imaging in multiple myeloma using dual‐energy CT
H Gong, FI Baffour, KN Glazebrook, NG Rhodes, CA Tiegs‐Heiden, ...
Medical physics 49 (10), 6346-6358, 2022
Upoważnienia: US National Institutes of Health
Upgraded standardized minimal residual disease detection by next-generation sequencing in multiple myeloma
Q Yao, Y Bai, A Orfao, S Kumar, CS Chim
The Journal of Molecular Diagnostics 22 (5), 679-684, 2020
Upoważnienia: National Natural Science Foundation of China
A comparative assessment of generalized anxiety, conduct and peer relationship problems among AIDS and other orphaned children in India
PK Sg, R SP, VS V, R Dandona
BMC psychiatry 16, 1-10, 2016
Upoważnienia: Wellcome Trust
Photon counting detector computed tomography: a new frontier of myeloma bone disease evaluation
J Cook, K Rajendran, A Ferrero, P Dhillon, S Kumar, F Baffour
Acta Haematologica 146 (5), 419-423, 2023
Upoważnienia: US National Institutes of Health
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
E Galanis, SK Anderson, E Twohy, NA Butowski, A Hormigo, D Schiff, ...
Neuro-Oncology Advances 4 (1), vdac041, 2022
Upoważnienia: US National Institutes of Health
Efficacy of thalidomide-or lenalidomide-based therapy in proliferative multiple myeloma
P Kapoor, S Kumar, SJ Mandrekar, KM Laumann, A Dispenzieri, MQ Lacy, ...
Leukemia 25 (7), 1195-1197, 2011
Upoważnienia: US National Institutes of Health
Clinical administration characteristics of subcutaneous and intravenous administration of daratumumab in patients with multiple myeloma at Mayo Clinic infusion centers
SA Soefje, C Carpenter, K Carlson, S Awasthi, TS Lin, S Kaila, D Tarjan, ...
JCO Oncology Practice 19 (4), e542-e549, 2023
Upoważnienia: US National Institutes of Health
Structural confirmation and spectroscopic signature of N-Allyl-2‑hydroxy-5-methyl-3-oxo-2, 3-dihydrobenzofuran-2-carboxamide and its monohydrate cluster
T Yadav, AK Vishwkarma, G Brahmachari, I Karmakar, P Yadav, S Kumar, ...
Journal of Molecular Structure 1267, 133566, 2022
Upoważnienia: Department of Science & Technology, India
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo
NW Cummins, J Baker, R Chakraborty, PG Dean, E Garcia-Rivera, ...
EClinicalMedicine 42, 2021
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy